OncView™ Podcast: Immunotherapy Response Monitoring in Melanoma
John Kirkwood, MD, PhD, discussed considerations for treating patients with melanoma using immunotherapy and how to properly monitor responses.
As part of its OncView™ video series, CancerNetwork® spoke with John Kirkwood, MD, PhD, director of the Melanoma Center at the University of Pittsburgh Medical Center Hillman Cancer Center, about using immunotherapy for treating melanoma and how to properly monitor responses in patients with metastatic melanoma.
In the video series, Kirkwood discussed the following:
- Treatment Options for Melanoma
- Considerations for Immunotherapy Use When Treating Melanoma
- Monitoring Responses to Melanoma Therapy
- Pseudoprogression in Melanoma Therapy
- ctDNA for Melanoma Treatment Monitoring
- Using ctDNA to Monitor Patients With Melanoma
- Taking Drug Holidays Amidst Melanoma Therapy
- Duration of Treatment for Melanoma
To watch more videos from the CancerNetwork® OncView™ series, visit cancernetwork.com/oncview.
Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
![A third of patients had a response [to lifileucel], and of the patients who have a response, half of them were alive at the 4-year follow-up.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F6b7c9a3270c71a70749ba86000cfc78a29d74309-2988x1702.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "A third of patients had a response [to lifileucel], and of the patients who have a response, half of them were alive at the 4-year follow-up.")
